Sarah Kathryn Rouan
CIK 1761366 · last filed 2026-01-05
Sarah Kathryn Rouan is a corporate insider who has filed 19 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for VKTX, was dated Jan 5, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $126.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$126.2K
3
19
-$2.22M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VKTX | Director | 4,390 | $28.75 | $126.2K | -$2.22M | 10 | 2026-01-05 |
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Director | 18,242 | $0.00 | $2 | $4.9K | 6 | 2021-07-07 |
| Viking Therapeutics, Inc. (VKTXW) Delisted | Director | — | $4.60 | — | $0 | 3 | 2021-01-06 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | VKTX | Grant (A) | +3,150 | $0 | EDGAR |
| 2025-04-08 | VKTX | Buy (P) | +1,240 | $29.9K | EDGAR |
| 2025-04-02 | VKTX | Buy (P) | +1,240 | $29.9K | EDGAR |
| 2025-01-06 | VKTX | Grant (A) | — | $0 | EDGAR |
| 2024-10-25 | VKTX | Mixed | — | -$836.1K | EDGAR |
| 2024-02-08 | VKTX | Mixed | — | -$493.2K | EDGAR |
| 2024-01-19 | VKTX | Mixed | — | -$441.9K | EDGAR |
| 2024-01-04 | VKTX | Grant (A) | — | $0 | EDGAR |
| 2023-01-04 | VKTX | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | VKTX | Grant (A) | — | $0 | EDGAR |